Company intelligence / Profile preview

AI InnoBio

Hong Kong (Sheung Wan), Hong Kong

Ownership: Private
Development stage: Other

Overview

Clinical trial results for the main product (Be FAIR COVID 19 Quick Test) demonstrated rapid, accurate results with cloud-based AI/ML analysis; deployment/roll-out in Hong Kong and demonstrated in international forums.

Therapeutic areas: NephrologyOncologyInfectious Diseases
Modalities: DeviceAI-enabled diagnostics
Industry: Molecular Diagnostics

Partnerships

Virusight Diagnostic (Israel)Technogenetics (Italy)

Beyond the preview

Go deeper on AI InnoBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AI InnoBio.

Explore the full profile